Safety Rates Drug Report: ETOPOSIDE. Graft versus host disease adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: ETOPOSIDE. Injury: Graft versus host disease Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 10 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
127041811	ETOPOSIDE.	Graft versus host disease	MYLAN	0.00		0	20160831	JP
127839421	ETOPOSIDE.	Graft versus host disease	AVENTIS	0.00		0	20160927	CN
127840301	ETOPOSIDE.	Graft versus host disease	AVENTIS	0.00		0	20160927	CN
127844431	ETOPOSIDE.	Graft versus host disease	AVENTIS	0.00		0	20160927	CN
127844561	ETOPOSIDE.	Graft versus host disease	AVENTIS	0.00		0	20160927	CN
127867101	ETOPOSIDE.	Graft versus host disease	AVENTIS	0.00		0	20160927	CN
127867241	ETOPOSIDE.	Graft versus host disease	AVENTIS	0.00		0	20160927	CN
127867721	ETOPOSIDE.	Graft versus host disease	AVENTIS	0.00		0	20160927	CN
127881271	ETOPOSIDE.	Graft versus host disease	AVENTIS	0.00		0	20160928	CN
127882451	ETOPOSIDE.	Graft versus host disease	AVENTIS	0.00		0	20160928	CN

|< 1/2 << Previous Page Page 1

Total Records: 10 Number of Pages: 1

Execution Time: 0.028788089752197 seconds (ucode:4943438). Developed by: James D. Barger